2,662
Views
10
CrossRef citations to date
0
Altmetric
Letters to the Editor

Fatal drug-drug interaction of brivudine and capecitabine

, , &
Pages 631-633 | Received 27 Nov 2008, Published online: 08 Jul 2009

Figures & data

Figure 1.  Metabolism of capecitabine and interaction with brivudine ((E)-5-(2-bromovinyl)-2′-deoxyuridine; BVDU). The activation of capecitabine to 5-FU involves 3 steps. 5-FU is metabolized to dihydrofluorouracil by dihydropyrimidine-dehydrogenase (DPD). Brivudine is metabolized by pyrimidine-nucleosidphosphorylase to bromovinyluracil (BVU), an irreversible inhibitor of DPD.BVDU-MP: brivudine monophosphate; BVDU-BP: brivudine biphosphate; BVDU-TP: brivudine triphosphate. (Adapted according to De Clercq) Citation[5]

Figure 1.  Metabolism of capecitabine and interaction with brivudine ((E)-5-(2-bromovinyl)-2′-deoxyuridine; BVDU). The activation of capecitabine to 5-FU involves 3 steps. 5-FU is metabolized to dihydrofluorouracil by dihydropyrimidine-dehydrogenase (DPD). Brivudine is metabolized by pyrimidine-nucleosidphosphorylase to bromovinyluracil (BVU), an irreversible inhibitor of DPD.BVDU-MP: brivudine monophosphate; BVDU-BP: brivudine biphosphate; BVDU-TP: brivudine triphosphate. (Adapted according to De Clercq) Citation[5]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.